Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Drug Hypersensitivity; Hypersensitivity | Phase 1 | ClinicalTrials |
| Diabetic Retinopathy; Hemorrhage; Vitreous Hemorrhage | Phase 3 | ClinicalTrials |
| Diabetic Retinopathy; Hemorrhage; Vitreous Hemorrhage | Phase 3 | ClinicalTrials |
| Drug Hypersensitivity; Hypersensitivity | Phase 1 | ClinicalTrials |
| Diabetic Retinopathy; Dissociative Disorders; Retinal Diseases; Vitreous Detachment | Phase 2 | ClinicalTrials |
CONTENTS